JT BAKER STRONTIUM 1000 UG/ML OR 10000 UG/ML
Flammability | 0 | |
Toxicity | 2 | |
Body Contact | 3 | |
Reactivity | 0 | |
Chronic | 0 | |
SCALE: Min/Nil=0 Low=1 Moderate=2 High=3 Extreme=4 |
Laboratory reagent.
Irritating to eyes and skin.
Accidental ingestion of the material may be damaging to the health of the individual. The material can produce chemical burns within the oral cavity and gastrointestinal tract following ingestion. Strontium salts induce vomiting and diarrhea when swallowed in large quantity. Absorbed strontium may produce painful contractions of the limbs and may be involved in abnormalities of the heart.
This material can cause eye irritation and damage in some persons. The material can produce chemical burns to the eye following direct contact. Vapors or mists may be extremely irritating.
This material can cause inflammation of the skin oncontact in some persons. The material can produce chemical burns following direct contactwith the skin. Skin contact is not thought to have harmful health effects, however the material may still produce health damage following entry through wounds, lesions or abrasions. Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected.
Not normally a hazard due to non-volatile nature of product. The material can cause respiratory irritation in some persons. The body's response to such irritation can cause further lung damage. The material is not thought to produce adverse health effects following inhalation (as classified using animal models). Nevertheless, adverse effects have been produced following exposure of animals by at least one other route and good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting.
Asthma-like symptoms may continue for months or even years after exposure to the material ceases. This may be due to a non-allergenic condition known as reactive airways dysfunction syndrome (RADS) which can occur following exposure to high levels of highly irritating compound. Key criteria for the diagnosis of RADS include the absence of preceding respiratory disease, in a non-atopic individual, with abrupt onset of persistent asthma-like symptoms within minutes to hours of a documented exposure to the irritant. A reversible airflow pattern, on spirometry, with the presence of moderate to severe bronchial hyperreactivity on methacholine challenge testing and the lack of minimal lymphocytic inflammation, without eosinophilia, have also been included in the criteria for diagnosis of RADS. RADS (or asthma) following an irritating inhalation is an infrequent disorder with rates related to the concentration of and duration of exposure to the irritating substance. Industrial bronchitis, on the other hand, is a disorder that occurs as result of exposure due to high concentrations of irritating substance (often particulate in nature) and is completely reversible after exposure ceases. The disorder is characterised by dyspnea, cough and mucus production.